Equities

Koei Chemical Co Ltd

4367:TYO

Koei Chemical Co Ltd

Actions
Basic MaterialsChemicals
  • Price (JPY)2,252.00
  • Today's Change0.00 / 0.00%
  • Shares traded200.00
  • 1 Year change-3.88%
  • Beta1.1947
Data delayed at least 20 minutes, as of May 01 2024 06:19 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Koei Chemical Co Ltd is a Japan-based company engaged in the manufacture, sale, import and export of chemical products. The Company operates in two business segments. The Fine Products segment is engaged in the manufacture and sale of medical and agricultural chemicals such as intermediates and raw materials for pharmaceuticals, veterinary drugs and agricultural chemicals, functional chemicals such as catalysts, solvents, polymer additives, resins, information technology (IT) related chemicals and photographic drugs, as well as other products. The Chemical Products segment is engaged in the manufacture and sale of multivalent alcohols such as various synthetic resin raw materials and paint raw materials, as well as other formaldehyde products.

  • Revenue in JPY (TTM)18.49bn
  • Net income in JPY62.58m
  • Incorporated1917
  • Employees387.00
  • Location
    Koei Chemical Co LtdKayabacho Takagi Bldg.1-8, Nihombashi Koami-choCHUO-KU 103-0016JapanJPN
  • Phone+81 368379300
  • Fax+81 368379307
  • Websitehttps://www.koeichem.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CanBas Co Ltd (Parent)0.00-1.07bn8.27bn12.00--2.63-----64.96-64.960.00174.810.00----0.00-40.62-65.86-42.95-79.11-------1,094.10----0.00-------45.41------
Tsubota Laboratory Inc246.60m-1.07bn9.11bn10.00--8.65--36.92-42.31-42.319.9441.170.10232.2029.1624,660,200.00-44.25---64.34---182.07---432.63--1.92-417.040.1046--48.96---41.18------
Stella Pharma Corp254.09m-765.17m9.34bn46.00--3.50--36.74-25.23-25.238.3285.550.06370.04563.585,523,718.00-19.18---20.37--82.76---301.14--11.90-1,173.120.2671--128.85---1.45------
Kohjin Bio Co Ltd-100.00bn-100.00bn9.46bn157.00--2.97----------634.95------------------------1.15--0.4102--20.16--41.20------
3-D Matrix Ltd3.74bn-1.06bn9.52bn108.00--15.49--2.55-14.90-14.9054.067.740.66530.46545.1934,630,130.00-18.91-57.69-23.28-77.3164.0440.76-28.43-205.342.33--0.8717--53.6358.87-29.09---7.69--
TMS Co Ltd0.00-960.04m9.91bn14.00--2.87-----25.89-25.890.0085.770.00-------26.14---26.78-----------------------11.51------
Linical Co Ltd12.52bn680.40m9.97bn759.0013.381.168.380.796430.1230.12554.28346.380.7251--3.9916,494,230.003.944.716.557.2333.1031.605.435.98--17,809.030.279345.368.326.5527.06-4.97-33.014.94
AnGes Inc152.99m-7.44bn10.67bn145.00--0.3726--69.72-39.40-39.400.8083131.520.00450.10378.401,055,069.00-21.97-28.50-25.69-33.1412.7139.42-4,861.66-6,726.821.75--0.0137--128.13-24.1749.45--12.11--
KOEI CHEMICAL COMPANY, LIMITED18.49bn62.58m11.07bn387.00176.560.5093.760.598712.7912.793,779.784,437.990.45991.304.5147,770,930.000.15573.760.2064.6824.9124.120.33856.660.53561.770.308935.807.550.4997-26.56-33.8215.6820.11
Veritas In Silico Inc360.36m33.05m11.23bn15.00330.056.92187.1831.165.245.2457.19250.05------24,023,730.00------------9.17--20.19--0.00--101.54--123.38------
Medinet Co Ltd724.63m-1.41bn11.53bn98.00--1.97--15.91-6.31-6.313.2322.880.122411.933.617,394,143.00-23.74-21.05-24.75-22.4717.7228.75-193.90-135.4019.58--0.00--4.40-7.90-14.66---17.67--
ReproCell Inc2.51bn-217.49m12.19bn92.00--1.51--4.86-2.56-2.5629.4890.900.30084.867.4427,247,390.00-2.61-9.37-2.80-10.1143.5538.78-8.68-38.1211.94--0.00--32.1626.1046.91--28.24--
Nano Mrna Co Ltd164.39m-1.05bn12.74bn17.00--3.66--77.51-14.94-14.942.3449.400.029518.962.609,669,765.00-18.85-25.13-23.29-26.0480.6784.69-638.22-538.318.95--0.2418---23.42-4.8430.33------
RaQualia Pharma Inc1.90bn-323.66m12.87bn67.00--2.10--6.77-14.99-14.9987.98283.050.28963.133.1528,376,150.00-4.932.13-5.292.2687.1188.49-17.025.3212.35--0.05670.00-34.8520.62-144.74--0.0967--
Healios KK121.00m-3.82bn13.34bn64.00--2.86--110.24-55.07-55.071.7851.710.008--0.39291,890,625.00-25.27-23.55-35.99-28.5283.47---3,152.89-6,580.16---13.680.6756--34.44--26.04---22.00--
Data as of May 01 2024. Currency figures normalised to Koei Chemical Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

0.02%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors Ltd.as of 29 Feb 2024699.000.01%
Goldman Sachs Asset Management BVas of 30 Jun 2023202.000.00%
American Century Investment Management, Inc.as of 31 Mar 2024200.000.00%
Data from 31 Dec 2023 - 25 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.